Investigating the Effects of Daily Consumption of Blueberry (Poly)Phenols on Vascular Function and Cognitive Performance

Healthy Clinical Trial

— BluFlow  

Official title:

Randomised, Double-blind, Placebo Controlled, Parallel Trial Investigating the Daily Effects of Blueberry (Poly)Phenol Consumption on Vascular Function and Cognitive Performance in Healthy Elderly Individuals

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04084457
• Other study ID #: BluFlow
• Status: Completed
• Phase: N/A
• Start date: September 4, 2019
• Est. completion date: April 17, 2020

Study information

• Verified date: July 2021
• Source: King's College London
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Foods rich in certain (poly)phenols, particularly flavonoids, such as berries and cocoa, have been shown to improve measures of vascular function as well as cognitive performance in human intervention studies. This is a randomized, double-blind, placebo controlled, parallel trial investigating the effects of daily blueberry (poly)phenol consumption on vascular function and cognitive performance in healthy elderly individuals. The study will be conducted at King's College London, Franklin-Wilkins Building. Eligible subjects will be healthy males and females aged 65-80.

Description:

To date no study has investigated whether daily blueberry consumption can induce an increase in cerebral blood flow, with subsequent improvements in vascular and cognitive function. In this study, the investigators aim to directly link daily blueberry consumption with improved vascular function, increased cerebral blood flow and positive cognitive outcomes in healthy elderly individuals. The investigators will use a large group of elderly individuals' representative of a healthy population, both males and females, aged 65-80 years to evaluate the health effects of daily blueberry consumption. The main aim is to investigate whether improvements in vascular and cognitive function previously seen after blueberry consumption can be seen following 3-months daily consumption in elderly individuals, and whether enhanced cognitive performance is correlated with increased cerebral blood flow. The investigators hypothesise that daily consumption of an anthocyanin rich blueberry drink will improve cognitive performance and vascular function, increasing cerebral blood flow, in healthy older individuals.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 53
• Est. completion date: April 17, 2020
• Est. primary completion date: April 17, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 65 Years to 80 Years

Eligibility

Inclusion Criteria:

• Participants will include 60 healthy male and female volunteers, aged 65-80.
• Volunteers will be able to understand the nature of the study and able to give signed written informed consent.
• Subjects willing to maintain their normal eating/drinking habits and exercise habits to avoid changes in body weight over the duration of the study.

Exclusion Criteria:

• Manifest cardiovascular diseases including coronary artery disease, cerebrovascular disease and peripheral artery disease.
• Hypertensive, as defined as SBP superior or equal to 140 mmHg or DBP superior or equal to 90 mmHg.
• Obese participants, defined as BMI superior or equal to 30.
• Diabetes mellitus and metabolic syndrome.
• Acute inflammation, terminal renal failure or malignancies.
• Allergies to berries or another significant food allergy.
• Subjects under medication or on vitamin/dietary supplements (within 2 weeks of baseline).
• Subjects who have lost more than 10% of their weight in the past 6 months or are currently on a diet.
• Subjects who reported participant in another study within one month before the study starts.
• Subjects who smoke cigarettes irregularly.
• MCI or dyslexic or unable to complete the cognitive function tasks for any reason such as visual impairments.
• Subjects who require chronic antimicrobial or antiviral treatment.
• Subjects with unstable psychological condition.
• Subjects with history of cancer, myocardial infarction, cerebrovascular incident.
• Any reason or condition that in the judgment of the clinical investigator(s) may put the subject at unacceptable risk or that may preclude the subject from understanding or complying with the study's requirements.

Related Conditions & MeSH terms

• Healthy
• Healthy Aging

Intervention

Dietary Supplement:
• Wild Blueberry powder
Powdered extract obtained from wild blueberries. A daily administration of 27g wild blueberry powder will be administered.
• Placebo
Identical formulation as the treatment matched for fibre and vitamin C

Locations

Country	Name	City	State
United Kingdom	Franklin-Wilkins Building, King's College London	London

Sponsors (2)

Lead Sponsor	Collaborator
King's College London	University of Reading

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Endothelial Function	Changes in flow-mediated dilation of the brachial artery (FMD) from baseline after 12-week consumption of blueberry vs control	Baseline and 12 weeks post-intervention
Primary	Cognitive function	Changes in cognitive function from baseline after 12-week consumption of blueberry vs control. Cognitive testing involves the participant conducting tasks administered on a tablet-style laptop. The participants will be conducting these tasks whilst cerebral blood flow measurements are taking place. The cognitive testing battery will consist of 4 tasks which are Auditory Verbal learning task, Corsi Blocks, Switching task and Serials 3's and 7's, including a mood assessment (PANAS).	Baseline and 12 weeks post-intervention
Secondary	Cerebral blood flow velocity (CBFv)	Changes in cerebral blood flow velocity (CBFv) from baseline after 12-week consumption of blueberry vs control. Trans-cranial blood flow will be assessed by Non-imaging transcranial Doppler sonography (TCD). Variables measured include resting and active mean blood flow velocity (cm/s).	Baseline and 12 weeks post-intervention
Secondary	Office systolic blood pressure	Changes from baseline office systolic blood pressure (mmHg) after 12-week consumption of blueberry vs control.	Baseline and 12 weeks post-intervention
Secondary	Pulse wave velocity (PWV)	Determine the changes in Pulse wave velocity (PWV) from baseline after 12-week consumption of blueberry vs control.	Baseline and 12 weeks post-intervention
Secondary	Augmentation Index (AIx)	Changes in augmentation Index (AIx) using a Sphygmocor device post consumption of a placebo or blueberry treatment	Baseline and 12 weeks post-intervention
Secondary	24-hour ambulatory systolic blood pressure	Determine the effect of the blueberry extract vs Placebo on 24-hour systolic blood pressure using a monitor, at 12 weeks post consumption. Variables include mean asleep, awake and total 24 h systolic blood pressure	Baseline and 12 weeks post-intervention
Secondary	Mood	Assessment using a self-reported questionnaire using the Positive and Negative Affect Schedule (PANAS).PANAS (The Positive and Negative Affect Schedule) to measure mood, where the participants will need to answer 20 questions using a 5-point likert scale that ranges from (1) not at all to (5) extremely. Dependent variables are composite positive affect and negative affect scores obtained by summing responses to positive or negative PANAS items, respectively.	Baseline and 12 weeks post-intervention
Secondary	Change in Blood lipids concentration (Total, HDL and LDL cholesterol, triglycerides)	Determine the effect of the blueberry extract vs Placebo on blood lipids (Total, HDL and LDL cholesterol, triglycerides), at 12 weeks post consumption.	Baseline and 12 weeks post-intervention
Secondary	Plasma blueberry (poly)phenol metabolites	Measured by liquid chromotography- mass spectrometry (LC/MS) 0 and 2 hours post consumption	Baseline and 12 weeks post-intervention
Secondary	Microbiome analysis	Stool sample collection involving an all-in-one kit for self-collection and stabilization of microbial DNA from faeces for gut microbiome profiling.	Baseline and 12 weeks post-intervention
Secondary	Urine blueberry polyphenol metabolites	Collected over a 24 hour period. Measured by liquid chromotography- mass spectrometry (LC/MS) 0 and 2 hours post consumption	Baseline and 12 weeks post-intervention
Secondary	Number of volunteers with treatment-related adverse events	The number of volunteers with treatment-related adverse events will be assessed by questionnaires and interviews.	Baseline and 12 weeks post-intervention
Secondary	Pulsatility index (PI)	Changes in pulsatility index (PI) from baseline after 12-week consumption of blueberry vs control. Trans-cranial blood flow will be assessed by Non-imaging transcranial Doppler sonography (TCD). Variables measured include resting and active PI (cm/s.	Baseline and 12 weeks post-intervention
Secondary	Office diastolic blood pressure	Changes from baseline office diastolic blood pressure (mmHg) after 12-week consumption of blueberry vs control.	Baseline and 12 weeks post-intervention
Secondary	24-hour ambulatory diastolic blood pressure	Determine the effect of the blueberry extract vs Placebo on 24-hour diastolic blood pressure using a monitor, at 12 weeks post consumption. Variables include mean asleep, awake and total 24 h diastolic blood pressure	Baseline and 12 weeks post-intervention